Literature DB >> 8662523

Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation.

J Wang1, K Walsh.   

Abstract

Proliferating murine C2C12 myoblasts can undergo either terminal differentiation or programmed cell death under conditions of mitogen deprivation. Unlike myoblasts, differentiated myotubes were resistant to apoptosis. During myogenesis the appearance of the apoptosis-resistant phenotype was correlated with the induction of the cyclin-dependent kinase (Cdk) inhibitor p21(CIP1) but not with the appearance of myogenin, a marker expressed earlier in differentiation. Forced expression of the Cdk inhibitors p21(CIP1) or p16(INK4A) blocked apoptosis during myocyte differentiation. These data indicate that induction of Cdk inhibitors may serve to protect differentiating myocytes from programmed cell death as well as play a role in establishing the postmitotic state.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662523      PMCID: PMC3641673          DOI: 10.1126/science.273.5273.359

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  25 in total

1.  DNA synthesis and myogenesis.

Authors:  F E STOCKDALE; H HOLTZER
Journal:  Exp Cell Res       Date:  1961-09       Impact factor: 3.905

2.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

3.  The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells.

Authors:  W Poluha; D K Poluha; B Chang; N E Crosbie; C M Schonhoff; D L Kilpatrick; A H Ross
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

5.  Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis.

Authors:  B Nadal-Ginard
Journal:  Cell       Date:  1978-11       Impact factor: 41.582

6.  Inhibition of ras-induced proliferation and cellular transformation by p16INK4.

Authors:  M Serrano; E Gómez-Lahoz; R A DePinho; D Beach; D Bar-Sagi
Journal:  Science       Date:  1995-01-13       Impact factor: 47.728

7.  Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation.

Authors:  W Gu; J W Schneider; G Condorelli; S Kaushal; V Mahdavi; B Nadal-Ginard
Journal:  Cell       Date:  1993-02-12       Impact factor: 41.582

8.  Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation.

Authors:  A F Lois; L T Cooper; Y Geng; T Nobori; D Carson
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

9.  Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.

Authors:  J Chen; P K Jackson; M W Kirschner; A Dutta
Journal:  Nature       Date:  1995-03-23       Impact factor: 49.962

10.  Inhibition of apoptosis by the retinoblastoma gene product.

Authors:  D A Haas-Kogan; S C Kogan; D Levi; P Dazin; A T'Ang; Y K Fung; M A Israel
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  98 in total

1.  Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival.

Authors:  Y Fujio; K Guo; T Mano; Y Mitsuuchi; J R Testa; K Walsh
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1).

Authors:  K Hiromura; J W Pippin; M L Fero; J M Roberts; S J Shankland
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

3.  Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21.

Authors:  M A Lawlor; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  Inactivation of p21 by E1A leads to the induction of apoptosis in DNA-damaged cells.

Authors:  D Chattopadhyay; M K Ghosh; A Mal; M L Harter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Carp, a cardiac ankyrin-repeated protein, and its new homologue, Arpp, are differentially expressed in heart, skeletal muscle, and rhabdomyosarcomas.

Authors:  Naoko Ishiguro; Takeshi Baba; Tsuyoshi Ishida; Kengo Takeuchi; Mitsuhiko Osaki; Nobuhito Araki; Eikichi Okada; Satsuki Takahashi; Masahiro Saito; Mari Watanabe; Chisato Nakada; Yoshiyuki Tsukamoto; Kenzo Sato; Kinji Ito; Masashi Fukayama; Shigeo Mori; Hisao Ito; Masatsugu Moriyama
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

6.  Differentiation of human malignant melanoma cells that escape apoptosis after treatment with 9-nitrocamptothecin in vitro.

Authors:  P Pantazis; D Chatterjee; Z Han; J Wyche
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

7.  Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes.

Authors:  Angélica Figueroa; Ana Cuadrado; Jinshui Fan; Ulus Atasoy; George E Muscat; Pura Muñoz-Canoves; Myriam Gorospe; Alberto Muñoz
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

8.  Enhanced myogenic differentiation by extracellular matrix is regulated at the early stages of myogenesis.

Authors:  Ramon C J Langen; Annemie M W J Schols; Marco C J M Kelders; Emiel F M Wouters; Yvonne M W Janssen-Heininger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Mar-Apr       Impact factor: 2.416

9.  Long-term growth selection of mice changes the intrinsic susceptibility of myogenic cells to apoptosis.

Authors:  Charlotte Rehfeldt; Ulla Renne; Matthias Wittstock; Eilhard Mix; Uwe K Zettl
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

10.  p21Cip1 is required for the development of monocytes and their response to serum transfer-induced arthritis.

Authors:  John C Scatizzi; Jack Hutcheson; Emily Bickel; James M Woods; Karolina Klosowska; Terry L Moore; G Kenneth Haines; Harris Perlman
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.